A biopsychosocial model of cystic fibrosis: Social and emotional functioning, adherence, and quality of life

Cystic Fibrosis

Volumn , Issue , 2016, Pages 468-481

  Barker, David ^a   Quittner, Alexandra L ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650461605     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Cystic Fibrosis Foundation. Patient Registry 2006 Annual Report, Bethesda, MD, 2008.
2. Quittner AL, Barker DH, Snell C, et al. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med 2008; 14:582-588.
3. Bronfenbrenner U. Making human beings human: bioecological perspectives on human development. Thousand Oaks, California: Sage Publications, 2004.
4. Quittner AL, DiGirolamo AM. Family adaptation to childhood disability and illness. In: Ammerman RT, Campo JV, eds. Handbook of Pediatric Psychology and Psychiatry. Boston, Massachusetts: Allyn & Bacon, 1998:70-102.
5. Martin LR, Williams SL, Haskard KB, et al. The challenge of patient adherence. Ther Clin Risk Manag 2005; 1:189-199.
6. Lerner RM, Theokas C, Bobek DL. Concepts and theories of human development: historical and contemporary dimensions. In: Bornstein MH, Lamb ME, eds. Developmental Science: An Advanced Textbook. 5th ed. Mahwah, New Jersey: Lawrence Erlbaum Associates, 2005:3-44.
7. Quittner AL, Modi AC, Roux AL. Psychosocial challenges and clinical interventions for children and adolescents with cystic fibrosis: a developmental approach. In: Brown RT, ed. Handbook of Pediatric Psychology in School Settings. Mahwah, New Jersey: Lawrence Erlbaum Associates, 2004:333-361.
8. Quittner AL, Opipari LC, Espelage DL, et al. Role strain in couples with and without a child with a chronic illness: associations with marital satisfaction, intimacy, and daily mood. Health Psychol 1998; 17:112-124.
9. Stark LJ, Quittner AL, Powers SW, et al. A randomized clinical trial of behavioral and nutritional education to improve calorie intake and weight in children with cystic fibrosis. Arch Pediatr Adolesc Med 2009; 163:915-921.
10. Götz I, Götz M. Cystic fibrosis: psychological issues. Paediatr Respir Rev 2000; 1:121-127.
11. Quittner AL, Opipari LC, Regoli MJ, et al. The impact of caregiving and role strain on family life: comparisons between mothers of children with cystic fibrosis and matched controls. Rehabil Psychol 1992; 37:289-304.
12. Williams B, Mukhopadhyay S, Dowell J, et al. From child to adult: an exploration of shifting family roles and responsibilities in managing physiotherapy for cystic fibrosis. Soc Sci Med 2007; 65:2135-2146.
13. Tluczek A, Koscik R, Farrell PM, et al. Psychosocial risk associated with newborn screening for cystic fibrosis: parents' experience while awaiting the sweat-test appointment. Pediatrics 2005; 115:1692-1703.
14. Ward C, Massie J, Glazner J, et al. Problem behaviours and parenting in preschool children with cystic fibrosis. Arch Dis Child 2009; 94(5):341-347.
15. Janicke DM, Mitchell MJ, Stark LJ. Family functioning in school-age children with cystic fibrosis: an observational assessment of family interactions in the mealtime environment. J Pediatr Psychol 2005; 30:179-186.
16. Mitchell MJ, Powers SW, Byars KC, et al. Family functioning in young children with cystic fibrosis: observations of interactions at mealtime. J Dev Behav Pediatr 2004; 25:335-346.
17. DeLambo KE, Ievers-Landis CE, Drotar D, et al. Association of observed family relationship quality and problem-solving skills with treatment adherence in older children and adolescents with cystic fibrosis. J Pediatr Psychol 2004; 29:343-353.
18. Modi AC, Marciel KK, Slater SK, et al. The influence of parental supervision on medical adherence in adolescents with cystic fibrosis: developmental shifts from pre to late adolescence. Child Health Care 2008; 37:78-92.
19. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-topatient transmission. Infect Control Hosp Epidemiol 2003; 24:S6-S52.
20. Quittner AL, Barker DH, Marciel KK, et al. Cystic fibrosis: a model for drug discovery and patient care. In: Roberts MC, Steele RG, eds. Handbook of Pediatric Psychology. New York: The Guilford Press, 2009: 271-286.
21. Graetz BW, Shute RH, Sawyer MG. An Australian study of adolescents with cystic fibrosis: perceived supportive and nonsupportive behaviors from families and friends and psychological adjustment. J Adolesc Health 2000; 26:64-69.
22. Modi A, Quittner AL, Boyle MP. Disclosure of chronic disease in adults with cystic fibrosis: the adult data for understanding lifestyle and transitions (ADULT) survey. Pediatr Pulmonol 2008; S31:445.
23. Kyngas H. Support network of adolescents with chronic disease: adolescents' perspective. Nurs Health Sci 2004; 6:287-293.
24. DiGirolamo AM, Quittner AL, Ackerman V, et al. Identification and assessment of ongoing stressors in adolescents with a chronic illness: an application of the behavior-analytic model. J Clin Child Adolesc Psychol 1997; 26:53-66.
25. Plante WA, Lobato D, Engel R. Review of group interventions for pediatric chronic conditions. J Pediatr Psychol 2001; 26:435-453.
26. Johnson KB, Ravert RD, Everton A. Hopkins teen central: assessment of an internet-based support system for children with cystic fibrosis. Pediatrics 2001; 107:E24.
27. Marciel KK, Saiman L, Quittell L, et al. Cell phone intervention to improve adherence: cystic fibrosis care team, patient, and parent perspectives. Pediatr Pulmonol (in press).
28. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132:231-237.
29. Smith BA, Modi AC, Quittner AL, et al. Co-morbidity of depression and cystic fibrosis in children and adolescents: associations with adherence to medical treatment cystic fibrosis. Pediatr Pulmonol (in press).
30. Goldbeck L, Besier T, Hinz A, et al.; and the TIDES study group. Prevalence of anxiety and depression in German patients with cystic fibrosis. Chest (under review).
31. Bregnballe V, Thastum M, Schiøtz PO. Psychosocial problems in children with cystic fibrosis. Acta Paediatr 2007; 96:58-61.
32. Havermans T, Colpaert K, Dupont LJ. Quality of life in patients with cystic fibrosis: association with anxiety and depression. J Cyst Fibros 2008; 7:581-584.
33. Anderson DL, Flume PA, Hardy KK. Psychological functioning of adults with cystic fibrosis. Chest 2001; 119:1079-1084.
34. Modi AC, Lim CS, Yu N, et al. A multi-method assessment of treatment adherence for children with cystic fibrosis. J Cyst Fibros 2006; 5:177-185.
35. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42:200-209.
36. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA 2002; 288:2880-2883.
37. Arias Llorente RP, Bousoño García C, Díaz Martín JJ. Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros 2008; 7:359-367.
38. Zindani GN, Streetman DD, Streetman DS, et al. Adherence to treatment in children and adolescent patients with cystic fibrosis. J Adolesc Health 2006; 38:13-7.
39. Quittner AL, Modi AC, Lemanek KL, et al. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol 2008; 33:916-936.
40. Quittner AL, Opipari LC. Differential treatment of siblings: interview and diary analyses comparing two family contexts. Child Dev 1994; 65:800-814.
41. Riekert KA, Mogayzel PJ, Bilderback A, et al. Medication adherence among children, adolescents and adults with CF. Pediatr Pulmonol 2007; S28:405.
42. Briesacher B, Andrade S, Fouayz IH, et al. Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy 2008; 28:437-443.
43. Barker DH, Monaco B, Quittner AL. Challenges in measuring adherence: relationships between self-report, diary, and electronic measures in adolescents with cystic fibrosis. In: National Conference on Child Health Psychology, April 2008, Miami, Florida.
44. Quittner AL, Davis MA, Modi AC. Health-related quality of life in pediatric populations. In: Roberts MC, ed. Handbook of Pediatric Psychology. 3rd ed. New York, New York: Guilford Publications, 2003:696-709.
45. Food and Drug Administration. Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. In: U.S. Department of Health and Human Services Food and Drug Administration, ed. 2006. Health Qual Life Outcomes 2006; 4:79.
46. Revivki DA, Erickson PA, Sloan JA, et al. Interpreting and reporting results based on patient reported outcomes. Value Health 2007; 10:S116-S124.
47. Detmar SB, Muller MJ, Schornagel JH, et al. Health-related quality of life assessments and patient-physician communication: a randomised controlled trial. JAMA 2002; 288.
48. Feeny D. Preference-based measures: utility and quality-adjusted life years. In: Fayers P, Hays R, eds. Assessing Quality of Life in Clinical Trials. Oxford: Oxford University Press, 2005:405-430.
49. Eiser C, Morse R. Quality-of-life measures in chronic diseases of childhood. Health Technol Assess 2001; 5:1-157.
50. Goss CH, Quittner AL. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007; 4:378-386.
51. Retsch-Bogart G, Quittner AL, Gibson RL, et al. Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis. Chest 2009; 135:1223-1232.
52. Quittner AL. Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med 1998; 4:326-331.
53. Quittner AL, Modi AC, Cruz I. Systematic review of health-related quality of life measures for children with respiratory conditions. Pediatric Respir Rev 2008; 9:220-232.
54. Quittner AL, Buu A, Messer MA, et al. Development and validation of the cystic fibrosis questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005; 128:2347-2354.
55. Palermo TM, Long AC, Lewandowski AS, et al. Evidence-based assessment of health-related quality of life and functional impairment in pediatric psychology. J Pediatr Psychol 2008; 33:983-996.
56. Modi AC, Quittner AL. Validation of a disease-specific measure of health-related quality of life for children with cystic fibrosis. J Pediatr Psychol 2003; 28:535-546.
57. Dobbin CJ, Bartlett D, Melehan K, et al. The effect of infective exacerbations on sleep and neurobehavioral function in cystic fibrosis. Am J Respir Crit Care Med 2005; 172:99-104.
58. Quittner AL, Schechter MS, Rasouliyan L, et al. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis. Chest (in press).
59. Quittner AL, Modi AC, Wainwright C, et al. Determination of the minimal clinically important difference (MCID) score for the cystic fibrosis questionnaire-revised (CFQ-R) respiratory symptoms scale in two populations of patients with cf and chronic pseudomonas aeruginosa airway infection. Chest 2009; 135:1610-1618.
60. McCoy KS, Quittner AL, Oermann C, et al. Inhaled aztreonam lysine for chronic airway pseudomonas aeruginosa in cystic fibrosis. Am J Respir Crit Care Med 2008; 178:921-928.
61. TM) in the treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection. Pediatr Pulmonol 2008; S31:301.
62. Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol 2006; 31:846-858.
63. Marciel KK, Cruz I, Barker DH, et al. Effectiveness of a pill swallowing program for young children with cystic fibrosis. Pediatr Pulmonol 2008; S31:458.
64. Glasscoe C, Lancaster GA, Smyth RL, et al. Parental depression following the early diagnosis of cystic fibrosis: a matched, prospective study. J Pediatr 2007; 150:185-191.
65. Yilmaz O, Sogut A, Gulle S, et al. Sleep quality and depression-anxiety in mothers of children with two chronic respiratory diseases: asthma and cystic fibrosis. J Cyst Fibros 2008; 7:495-500.
66. Meltzer LJ, Mindell JA. Impact of a child's chronic illness on maternal sleep and daytime functioning. Arch Intern Med 2006; 166:1749-1755.
67. Halligan SL, Murray L, Martins C, et al. Maternal depression and psychiatric outcomes in adolescent offspring: a 13-year longitudinal study. J Affect Disord 2007; 97:145-154.
68. Quittner AL, Barker DH, Geller D, et al. Effects of maternal depression on electronically monitored enzyme adherence and changes in weight for children with CF. J Cyst Fibros 2007; 6:77.
69. Snell C, Barker DH, Marciel KK, et al. Paradoxical relationships between parental depression and pulmonary functioning in cystic fibrosis: the role of treatment burden and daily mood. Pediatr Pulmonol 2008; S31:454.
70. Badlan K. Young people living with cystic fibrosis: an insight into their subjective experience. Health Soc Care Community 2006; 14:264-270.
71. Smith BA, Wood BL. Psychological factors affecting disease activity in children and adolescents with cystic fibrosis: medical adherence as a mediator. Curr Opin Pediatr 2007; 19:553-558.
72. D'Auria JP, Christian BJ, Richardson LF. Through the looking glass: children's perceptions of growing up with cystic fibrosis. Can J Nurs Res 1997; 4:99-112.
73. Fiese BH, Everhart RS. Medical adherence and childhood chronic illness: family daily management skills and emotional climate as emerging contributors. Curr Opin Pediatr 2006; 18:551-557.
74. Wysocki T, Harris MA, Buckloh LM, et al. Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control. J Pediatr Psychol 2006; 31:928-938.
75. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004; 23:207-218.
76. Barker DH, Cohen LM, Driscoll KA, et al. It takes a village: what family, friends and teachers do to facilitate disease management in adolescents with cystic fibrosis. Pediatr Pulmonol 2008; S31:452.
77. Palmer ML, Boisen LS. Cystic fibrosis and the transition to adulthood. Soc Work Health Care 2002; 36:45-58.
78. Pfeffer PE, Pfeffer JM, Hodson ME. The psychosocial and psychiatric side of cystic fibrosis in adolescents and adults. J Cyst Fibros 2003; 2:61-68.
79. Hogg M, Braithwaite M, Bailey M, et al. Work disability in adults with cystic fibrosis and its relationship to quality of life. J Cyst Fibros 2007; 6:223-227.
80. 1 in adults with cystic fibrosis. Pediatr Pulmonol 2004; 38:413-418.
81. Berge JM, Patterson JM, Goetz D, et al. Gender differences in young adults' perceptions of living with cystic fibrosis during the transition to adulthood: a qualitative investigation. Fam Syst Health 2007; 25:190-203.
82. Quittner AL, Modi AC, Boyle MP. The role of independence in daily functioning for adults with cystic fibrosis: results from the adult data for understanding lifestyle and transitions (ADULT) survey. Pediatr Pulmonol 2008; S31:445.
83. Myers LB, Horn SA. Adherence to chest physiotherapy in adults with cystic fibrosis. Journal of Health Psychol 2006; 11:915-926.
84. McGuffie K, Sellers DE, Sawicki GS, et al. Self-reported involvement of family members in the care of adults with CF. J Cyst Fibros 2008; 7:95-101.
85. Chapman E, Landy A, Lyon A, et al. End of life care for adult cystic fibrosis patients: facilitating a good enough death. J Cyst Fibros 2005; 4:249-257.
86. Brumfield K, Lansbury G. Experiences of adolescents with cystic fibrosis during their transition from paediatric to adult health care: a qualitative study of young Australian adults. Disabil Rehabil 2004; 26:223-234.
87. Parker HW. Transition and transfer of patients who have cystic fibrosis to adult care. Clin Chest Med 2007; 28:423-432.
88. Patton SR, Graham JL, Varlotta L, et al. Measuring self-care independence in children with cystic fibrosis: the self-care independence scale (SCIS). Pediatr Pulmonol 2003; 36:123-130.
89. Blum RW. Transition to adult health care: setting the stage. J Adolesc Health 1995; 17:3-5.
90. Schidlow DV. Transition in cystic fibrosis: much ado about nothing? a pediatrician's view. Pediatr Pulmonol 2002; 33:325-326.
91. White T, Miller J, Smith GL, et al. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychiatry 2008; 18:96-104.
92. Cruz I, Marciel KK, Quittner AL, et al. Anxiety and depression in CF. Semin Respir Crit Care Med 2009; 30:569-578.
93. Quittner AL. Controlled trial of two adherence promotion interventions for cystic fibrosis. In: Health Economics & Outcomes Group, Novartis Pharmaceuticals, 2008.